Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Gen Virol ; 85(Pt 7): 2023-2034, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15218188

RESUMO

Full-length sequences of the Epstein-Barr virus (EBV) gene for latent membrane protein (LMP)-1 from 22 nasopharyngeal carcinoma (NPC) biopsy specimens and 18 non-neoplastic counterparts (NPI) were determined. Relative to the B95-8 strain, the amino acid sequences of the toxic-signal and transformation domains were changed variably in NPC and NPI specimens; in contrast, no change was observed in the NF-kappaB (nuclear factor kappaB) activation domain. HLA typing revealed that 47 % of NPC and 31 % of NPI specimens were HLA A2-positive. A major A2-restricted epitope within LMP-1 (residues 125-133) was analysed. At residue 126, a change of L-->F was detected in 91 % (20/22) of NPC and 67 % (12/18) of NPI specimens. In addition, a deletion at residue 126 was detected in one NPC sample from Taiwan. At residue 129, a change of M-->I was observed in all samples, regardless of whether they were NPC or NPI. The changes in this peptide between NPC and NPI specimens, including mutation and deletion, are statistically significant (P<0.05). A recent report indicated that this variant sequence is recognized poorly by epitope-specific T cells. Genotyping results indicated that 96 % of NPC and 67 % of NPI samples carried a type A virus. By scanning the entire sequence of LMP-1, eight distinct patterns were identified. Detailed examination of these patterns revealed that type A strains are more prevalent in NPC than in NPI specimens and are marked by the loss of an XhoI site, the presence of a 30 bp deletion and the presence of a mutated, A2-restricted, T cell target epitope sequence. These results suggest that an EBV strain carrying an HLA A2-restricted 'epitope-loss variant' of LMP-1 is prevalent in NPC in southern China and Taiwan.


Assuntos
Antígeno HLA-A2/genética , Herpesvirus Humano 4/genética , Neoplasias Nasofaríngeas/patologia , Neoplasias Nasofaríngeas/virologia , Proteínas da Matriz Viral/química , Sequência de Aminoácidos , Substituição de Aminoácidos , Sequência de Bases , China , Primers do DNA , Epitopos/genética , Variação Genética , Herpesvirus Humano 4/isolamento & purificação , Humanos , Complexo Principal de Histocompatibilidade/genética , NF-kappa B/metabolismo , Fragmentos de Peptídeos/química , Reação em Cadeia da Polimerase , Mapeamento por Restrição , Taiwan
2.
Antiviral Res ; 62(1): 27-36, 2004 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-15026199

RESUMO

Previous reports have shown that HIV-LTRcat constructs stably transfected in HeLa cells are inducible after exposure to UV light. We have optimized this system for studying the effect of drugs on HIV-1 gene expression. The maximum UV response was observed in quiescent stationary cells stimulated with fresh medium for 3h. Glycyrrhizic acid suppressed UV-induced HIV gene expression in a concentration-dependent manner. The inhibitory effect was strongest when GL was added immediately after UV exposure; it was still evident when GL was added at 5 h, it was completely lost at 10 h, after UV exposure. The inhibitory effect was even more pronounced if the cells were pretreated with sub-effective dose (0.0012 mM) of GL prior to UV exposure. The IC50 values with and without pretreatment were 0.04 and 0.38 mM, respectively. Cell proliferation and viability were not affected by GL at doses as high as 2.4 mM. The inhibitory effect of GL on UV-induced CAT activity correlated with the complete inhibition of binding activities of NF-kappaB p65, NF-kappaB p50, c-Fos, and c-Rel. Thus, the UV-based bioassay as proposed here can be exploited for the routine screening of the compounds that interfere with HIV-1 gene expression.


Assuntos
Fármacos Anti-HIV/farmacologia , Expressão Gênica/efeitos dos fármacos , Ácido Glicirrízico/farmacologia , HIV-1/efeitos dos fármacos , HIV-1/genética , Testes de Sensibilidade Microbiana , Raios Ultravioleta , Bioensaio/métodos , Cloranfenicol O-Acetiltransferase/genética , Cloranfenicol O-Acetiltransferase/metabolismo , Regulação Viral da Expressão Gênica , Genes Reporter , Repetição Terminal Longa de HIV , HIV-1/metabolismo , HIV-1/efeitos da radiação , Células HeLa , Humanos , NF-kappa B/biossíntese , Subunidade p50 de NF-kappa B , Regiões Promotoras Genéticas , Proteínas Proto-Oncogênicas c-fos/biossíntese , Proteínas Proto-Oncogênicas c-rel/biossíntese , Fator de Transcrição RelA , Fatores de Transcrição/biossíntese , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...